We discuss the case of a young patient presenting with euglycemic DKA. Say what? How common is this entity and what is the impact of a new class of diabetic medication? We answer these important questions and much more on this episode.
You can get CME credit for this episode here! Click here for CME Account Creation Instructions
Bryan Hayes rejoins the podcast to discuss some great pearls and pitfalls with select medications used to resuscitate and treat critically ill patients. This...
Critically ill patients commonly develop a dysregulated inflammatory response. Corticosteroids are hypothesized to be beneficial due to their anti-inflammatory properties. In recent years, several...
The use of tranexamic acid (TXA) has markedly increased since the results of the CRASH-II trial were published. In addition to its use in...